GSK's Consumer Segment Grows 7% With Heavy Investment In R&D And A&P

Increased investment in brand innovation and high-quality, high-volume advertising are the "underpinning" of GlaxoSmithKline's consumer segment's "spectacular year," according to CEO Andrew Witty